Context Survival following high-risk cancer surgery, such as pancreatectomy
and esophagectomy, is superior at hospitals where high volumes of these pr
ocedures are per formed. Conflicting evidence exists as to whether the asso
ciation between hospital experience and favorable health outcomes also appl
ies to more frequently performed operations, such as those for colon cancer
.
Objective To determine whether hospital procedure volume predicts survival
following colon cancer surgery.
Design, Setting, and Participants Retrospective cohort study of data from t
he Surveillance, Epidemiology and End Results-Medicare linked database on 2
7986 colon cancer patients aged 65 years and older who had surgical resecti
on for primary adenocarcinoma diagnosed between 1991 and 1996.
Main Outcome Measures Thirty-day postoperative mortality and overall and ca
ncer-specific long-term survival, by hospital procedure volume.
Results We found small differences in 30-day postoperative mortality for pa
tients treated at low- vs high-volume hospitals (3.5% at hospitals in the t
op-volume quartile vs 5.5% at hospitals in the bottom-volume quartile). How
ever, the correlation was statistically significant and persisted after adj
usting for age at diagnosis, sex, race, cancer stage, comorbid illness, soc
ioeconomic status, and acuity of hospitalization (P<.001). The association
was evident for subgroups with stage I, II, and III disease. Hospital Volum
e directly correlated with survival beyond 30 days and also was not attribu
table to differences in case mix (P<.001). The association between hospital
volume and long-term survival was concentrated among patients with stage I
I and III disease (P<.001 for both). Among stage III patients. Variation in
use of adjuvant chemotherapy did not explain this finding.
Conclusion Our data suggest that hospital procedure volume predicts clinica
l outcomes following surgery for colon cancer, although the absolute magnit
udes of these differences are modest in comparison with the variation obser
ved for higher-risk cancer surgeries.